Opioid use disorder
-
Bicycle Health, Albertsons Form Partnership To Expand Access to OUD Treatment
Through a new partnership, Bicycle Health providers can prescribe patients buprenorphine extended release injections (otherwise known as Sublocade), which can be administered by a pharmacist at an Albertsons pharmacy.
-
Reading Between the Lines of the DEA’s Proposed Rules on Telemedicine
In some ways, the Drug Enforcement Agency’s (DEA) proposed rules for prescribing controlled substances via telemedicine are a sign of progress. Behavioral health could be getting some much-needed clarity, but at what cost?
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
MedCity Influencers, BioPharma, Legal
Relying on Primary Care Physicians to Treat Opioid Use Disorder Fails Both Patients and Providers
The new DEA ruling is doing a disservice not only to people with OUD, but to the entire medical care system—exacerbating a condition that will most likely lead to death.
-
Study: More OUD Patients Stay in Treatment When Offered Buprenorphine via Telemedicine
Patients with opioid use disorder are more likely to stick with their treatment plan when offered buprenorphine via telemedicine, according to a new study. The study involved 1,378 patients, and their 180-day treatment retention rate was 56.4%.
-
New Collaboration Brings Opioid Use Disorder Treatment to Formerly Incarcerated Patients
The collaboration, which was announced last week, is between Bicycle Health, Wellpath and the Federal Bureau of Prisons. It will provide virtual opioid use disorder services to those living in the Bureau’s residential reentry centers in 42 states.
-
Virtual Substance Use Disorder Companies Sound Alarm Over PHE Ending
The Covid-19 public health emergency waived a rule that required a practitioner to conduct an in-person medical exam before prescribing controlled substances via telemedicine. Once the public health emergency ends on May 11, those with substance use disorder could be greatly affected, experts are warning.
-
MedCity Influencers, Health Tech, Legal
Expanding Telehealth Access Not Reducing it Will Continue Saving Lives, Mitigating Costs of the Opioid Crisis
Protectionism against (and fear of) telehealth on display from companies like Walmart and states like Alabama threaten the only effective and scalable solution to America’s opioid epidemic.
-
How EmpiRx Health’s value-based model led to less drug spending on mental health, decreased opioid use
EmpiRx found in its data that pharmacy claims for behavioral health treatments increased 9.4% from 2020 to 2021. For antidepressants, utilization increased 12% during this time period, but per claim spend fell 1.8%. ADHD medications saw a 20.2% increase in utilization and a 9.1% decrease in per claim spend.
-
OIG: Over 50,000 Medicare Part D beneficiaries experienced an opioid overdose in 2021
Over 1 million Medicare beneficiaries had a diagnosis for opioid use disorder in 2021. But despite this high number, only 18% received medication to treat their disorder.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Consumer / Employer, Health Tech
Evernorth taps Bicycle Health for virtual opioid use disorder treatment
Bicycle Health provides medication for addiction treatment. Through its telehealth platform, it also offers a team of medical experts, a customized treatment plan, same-day prescription refills for medication management, peer support groups and therapy.
-
Most people with opioid use disorder don’t get meds for it, but these 3 changes could help
Medications that treat opioid use disorder (OUD) — such as methadone, buprenorphine and extended-release naltrexone — are proven to save lives. However, a new study revealed that less than 15% of Americans with OUD receive these medications. Its lead author laid out three actions the U.S. should prioritize to increase access.
-
Addiction treatment startup Quit Genius raises $64M
The startup began with digital tobacco cessation programs, but recently expanded to programs for alcohol use disorder and opioid use disorder. The $64 million funding round was led by Kinnevik and Atomico.
-
Health IT, Startups, Health Tech
Report: Addiction treatment apps pose privacy risks
Most apps offering opioid use disorder treatment have access to sensitive identifying information of their users, according to an analysis of 10 of them.
-
Providers watch legislation that would extend telehealth treatment for substance use
Temporary policy changes during the Covid-19 pandemic let people access substance use treatment over telehealth for the first time. Now, healthcare providers and policymakers are watching legislation that would allow patients to continue to access these services virtually.
-
In claims analysis, Pear finds digital therapeutic for opioid use disorder decreased medical costs
In a review of real-world claims data, Pear Therapeutics found that its digital therapeutic for opioid use disorder resulted in a reduction in spending $2,150 per patient over six months.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
